Cataract Clinical Trial
Official title:
Spectacle Independence and Overall Satisfaction With Bilateral Implantation of the AcrySof® Panoptix® Toric Intraocular Lens
NCT number | NCT04128514 |
Other study ID # | BF-19-001 |
Secondary ID | |
Status | Terminated |
Phase | |
First received | |
Last updated | |
Start date | October 11, 2019 |
Est. completion date | March 10, 2022 |
Verified date | March 2022 |
Source | Eye Center of North Florida |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study was designed to assess the spectacle independence and satisfaction of patients receiving the AcrySof® Panoptix® Toric intraocular lens (IOL) after uneventful cataract surgery.
Status | Terminated |
Enrollment | 15 |
Est. completion date | March 10, 2022 |
Est. primary completion date | March 10, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years and older |
Eligibility | Inclusion Criteria Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. - Presenting for uncomplicated bilateral cataract surgery and have an interest in spectacle independence using a multifocal toric IOL option - Gender: Males and Females. - Age: 40 or older. - Willing and able to provide written informed consent for participation in the study. - Willing and able to comply with scheduled visits and other study procedures. - Have good ocular health, with no pathology that compromises visual acuity (outside of residual refractive error and cataract) - Have regular corneal astigmatism with a magnitude that can be treated with a toric IOL in the approved range (T3-T6) for the Panoptix lens. - Have 20/32 (0.2 logMAR) or better potential acuity in both eyes Exclusion Criteria If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study. - Irregular astigmatism (e.g. keratoconus) - Corneal pathology (e.g. scar, dystrophy, pterygium, moderate-to-severe dry eye) - Monocular status (e.g. amblyopia) - Previous radial keratotomy, corneal refractive surgery or other corneal surgery (e.g. corneal transplant, DSAEK, lamellar keratoplasty) - Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy) - Diabetic retinopathy - Macular pathology (e.g. ARMD, ERM) - History of retinal detachment - Subjects who have an acute or chronic disease or illness that would confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness), that are known to affect postoperative visual acuity. - Participation in any investigational drug or device trial within the previous 30 days prior to the start date of this trial (or currently participating). The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial. Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness. |
Country | Name | City | State |
---|---|---|---|
United States | Eye Center of North Florida | Panama City | Florida |
Lead Sponsor | Collaborator |
---|---|
Eye Center of North Florida | Science in Vision |
United States,
Akman A, Asena L, Ozturk C, Gür Güngör S. Evaluation of quality of life after implantation of a new trifocal intraocular lens. J Cataract Refract Surg. 2019 Feb;45(2):130-134. doi: 10.1016/j.jcrs.2018.12.003. Epub 2019 Jan 3. — View Citation
Morlock R, Wirth RJ, Tally SR, Garufis C, Heichel CWD. Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation. Am J Ophthalmol. 2017 Jun;178:101-114. doi: 10.1016/j.ajo.2017.03.018. Epub 2017 Mar 22. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Spectacle independence - emmetropia | Percent of patients with = 0.5D of refractive cylinder and = 0.50D of absolute residual spherical equivalent refraction postoperatively who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire, or PRSIQ1 - "a little of the time" or "none of the time") | 3 months | |
Secondary | Binocular uncorrected distance visual acuity | Binocular distance visual acuity | 3 months | |
Secondary | Binocular uncorrected intermediate visual acuity | Binocular intermediate visual acuity | 3 months | |
Secondary | BInocular uncorrected near visual acuity | Binocular near visual acuity | 3 months | |
Secondary | Binocular best-corrected distance visual acuity | Binocular best-corrected distance visual acuity | 3 months | |
Secondary | Binocular distance-corrected intermediate visual acuity | Binocular distance-corrected intermediate visual acuity | 3 months | |
Secondary | Binocular distance-corrected near visual acuity | Binocular distance-corrected near visual acuity | 3 months | |
Secondary | Spherical equivalent refraction | Spherical equivalent refraction | 3 months | |
Secondary | Residual astigmatism | Residual astigmatism | 3 months | |
Secondary | Uncorrected preferred reading distance | Uncorrected preferred reading distance | 3 months | |
Secondary | Monocular corrected distance visual acuity | Monocular corrected distance visual acuity | 3 months | |
Secondary | Spectacle independence - overall | Percent of all patients who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire, or PRSIQ1 - "a little of the time" or "none of the time") | 3 months | |
Secondary | Binocular uncorrected visual acuity at preferred reading distance | Binocular uncorrected visual acuity at preferred reading distance | 3 months | |
Secondary | VFQ-14 | Questionnaire responses on VFQ-14 visual function questionnaire | 3 months | |
Secondary | Choose lens again | Percent of patients who would choose this lens modality again. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |